Search form

Home
LoginSubscribe
  • Home
  • Country Intelligence
  • Industry Directory
  • Offsets / IC
  • Tenders
    • Haiti(0/week)
    • Guyana(0/week)
    • Honduras(0/week)
    • Jamaica(0/week)
    • Netherlands Antilles(0/week)
    • View all (0/week)
  • News
    • United States(1202/week)
    • Manufacturing(600/week)
    • Energy(442/week)
    • Technology(1144/week)
    • Other Manufacturing(389/week)
  • Events
  • About us
    • Who we are
    • Our People
    • Partners
    • Contact us
  • LinkedIn
  • Login
  • Twitter
  • Register
  • Home
  • News

Apoptosis

May 31, 2020
(ASCO2020) Ascentage Pharma Presents Latest Clinical Data of Apoptosis Targeting Drug Candidates, Showing Promising Clinical Effects with Combination Therapies
May 19, 2020
Vividion Therapeutics Announces Drug Discovery Collaboration with Roche Focused on Novel E3 Ligases
May 15, 2020
Ascentage Pharma to Present Six Abstracts at 2020 AACR Annual Meeting
Mar 29, 2020
Ascentage Pharma Releases 2019 Annual Results, Reports Increased Investment in R&D and Advances in Global Clinical Development
Mar 23, 2020
Ascentage Pharma Announces First Patient Dosed in the Global Phase Ib/II Clinical Study of Bcl-2 Inhibitor APG-2575 in the United States
Nov 13, 2019
PMV Pharma Secures $62 Million in Series C Financing To Develop Cancer Drugs Targeting p53
Aug 05, 2019
Aprea Therapeutics Appoints Scott Coiante as Chief Financial Officer
Jul 14, 2019
Ascentage Pharma announces first patient dosed in Phase I clinical trial of APG-2575 in China as the first China-made Bcl-2 Inhibitor
Jun 03, 2019
Ascentage Pharma presents new clinical data of apoptosis-targeted drug candidates APG-115 and APG-1387 at 2019 ASCO
May 07, 2019
New Gene Therapies Hold Out Promise for Patients
Apr 16, 2019
Aprea Therapeutics Receives FDA Fast Track Designation and Orphan Drug Designation for APR-246 for the Treatment of Myelodysplastic Syndromes (MDS)
Apr 11, 2019
Higher Oxygen Levels Could Increase Effectiveness of New Line of Brain Cancer-Killing Drugs
Apr 03, 2019
Actinium Highlights Actimab-A and Venetoclax Synergies Observed in New Studies Presented at AACR
Mar 25, 2019
Ascentage Pharma Announces Nine Abstracts To Be Presented at the 2019 American Association for Cancer Research Annual Meeting
Mar 25, 2019
Aprea Therapeutics Appoints Dr. Eyal C. Attar as Chief Medical Officer
Mar 21, 2019
Mount Sinai and IBM Researchers Uncover Key to Greater Efficacy in Cancer Treatment
Jan 08, 2019
Ascentage Pharma Announces New License with Unity Biotechnology
Jan 06, 2019
Ascentage Pharma and MD Anderson Cancer Center Announce Strategic Alliance in Cancer Drug Development
Nov 30, 2018
Aprea Therapeutics Closes EUR 50 Million Financing
Nov 22, 2018
Global Apoptosis Assays (Caspase, Annexin V, DNA Fragmentation, Mitochondrial Assay) Market to 2023
  •  
  • Page 1
  • ››

Latest News

May 24, 2025

ATS Announces Settlement with EV Customer, Preliminary Fourth Quarter 2025 Results and Fourth Quarter...

May 24, 2025

HAFNIA LIMITED: Mandatory notification of trade by primary insider

May 24, 2025

U. S. Steel Statement on President Trump’s Leadership

May 24, 2025

Protolabs Announces Inducement Awards Under NYSE Rule 303A.08

May 24, 2025

You're Invited: Celebrate the Grand Re-Opening of the Dearborn Area Board of REALTORS® Association...

May 24, 2025

Huawei ICT Competition 2024-2025 Global Final Concludes: AI Empowers Education Transformation and ICT Talent...

May 24, 2025

Edimakor V4.0.0 Launches with AI Singing Photos & AI Animation

May 24, 2025

French taxi drivers threaten airports, French Open tennis in standoff

View all News

Agenda

23
September
United KingdomLondon, UK
Countering Explosive Threat & Demining conference, September 23 - 24, 2025, London, UK
Countering Explosive Threat & Demining conference | September 23 - 24, 2025 | London, UK The Countering Explosive...
View All Events

SUBSCRIBE

to Epicos.com
Please register in order to have access to personalized daily information on world-wide A&D industry developments and business opportunities.
Subscribe

REGISTER

for Epicos.com Newsletter
Sign up for our free newsletters and receive twice a week news and intelligence regarding the Aerospace & Defence Industry, meticulously selected by our editorial team.
Sign Up
Home
  • SIGN UP FOR NEWSLETTER
  • NEWSLETTER ARCHIVE
  • ADVERTISE WITH US
  • CONTACT US
  • PRIVACY POLICY
  • INFORMATION SECURITY POLICY
© 2025 EPICOS
Made by Wedia